Th2 cells release cytokines such as IL-4, IL-5, and IL-6 and are involved in allergic and inflammatory immunity. 20 A higher ratio of Th2 cytokines to Th1 cytokines has been associated with increased risks of aeroallergy and asthma. 18, 19 Further research on this topic would enhance the epidemiologic literature on plasticizing chemicals and atopy.
Plasticizing chemicals can cross the placental barrier, 21, 22 and prenatal exposures may have greater impact on immune system functioning than later exposures. 23 We measured urinary concentrations of eight phthalate metabolites and BPA at two time points during pregnancy.
Our primary objective was to analyze associations of prenatal HMW phthalate and BPA biomarkers with asthma, aeroallergies, eczema, and lung function at age 7, and our secondary objective was to analyze associations with T helper 1 (Th1) and Th2 cell percentages in whole blood at ages 2, 5, and 7. This is the first study to examine associations between in utero concentrations of these biomarkers and cytokine levels in childhood, and one of the first studies to examine atopic illnesses and cytokine levels in the same study.
| ME THODS

| Study population
The Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) has followed children living in the Salinas
Valley, California, from birth to age 16. 24 Women attending first prenatal care visits at local clinics were screened for eligibility in 1999-2000. Women were invited to participate if they spoke Spanish or English, were ≤20 weeks' pregnant, were ≥18 years old, qualified for MediCal (low-income health insurance), and planned to deliver at the county hospital. Participant mothers were primarily Mexican-born, Spanish-speaking, and lived with or were farmworkers. Of the 601 women enrolled, 531 were followed through a live birth. Of these, 517 children had at least one prenatal HMW phthalate or BPA measurement (101 children each was missing both prenatal samples for MBzP, MCNP, MCOP, and MCPP, and metabolites for DEHP, and 27 children were missing both prenatal samples for BPA). Of the 517 children with at least one prenatal biomarker measurement, 167 were missing data on probable asthma; 180 were missing data on aeroallergies; 181 were missing data on eczema; 219 did not have measurements for with data on at least one prenatal biomarker and one outcome.
This study conforms to recognized ethical standards and was approved by the Office for the Protection of Human Subjects (OPHS)
at UC Berkeley. The Centers for Disease Control and Prevention (CDC) deferred to the OPHS. Mothers gave written informed consent, and children verbally assented at age 7.
| Questionnaire data collection
Mothers completed interviewer-administered, structured questionnaires in English or Spanish twice during pregnancy, at delivery, and when children were 6 months old and 1, 2, 3.5, 5, and 7 years old.
During the first pregnancy interview, questionnaires asked about maternal age, education, country of birth, years lived in the United
States, parity, family income, and family history of asthma (mother, father, or siblings).
| Exposure assessment
Mothers provided spot urine samples at two interviews during pregnancy (first interview: mean 13 weeks' gestation, range 5-27; second interview: mean 26 weeks' gestation, range [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . Phthalate-and BPA-free polypropylene urine cups were used to collect urine, which was aliquoted into glass vials and stored at −80°C until shipment to the CDC.
We used solid phase extraction coupled with isotope dilution 25 and BPA. 26 Concentrations were reported in ng/mL of urine, and limits of detection ranged from 0.2 to 0.5 ng/mL. Concentrations below the limits of detection were assigned the instrument-reading values, if available, or an imputed value below the limits of detection selected randomly from the log-normal distribution using maximum likelihood estimation. 27 We combined mono-2-ethylhexyl phthalate, mono-(2-ethyl-5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-oxohexyl) phthalate, and mono-(2-ethyl-5-carboxypentyl) phthalate to create a molar sum of DEHP
metabolites (∑DEHP).
A handheld refractometer (National Instrument Company Inc, Baltimore, Maryland) was used to measure urinary specific gravity.
We imputed urinary specific gravity based on urinary creatinine for 81 samples missing specific gravity measurements by regressing specific gravity on creatinine and multiplying the coefficient by existing creatinine values to generate missing specific gravity values.
We used the formula (analyte concentration*(1.024-1))/(sample specific gravity − 1) to correct for urinary dilution.
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| Outcome Assessment
The primary outcomes for this study were probable asthma, aeroallergies, and eczema at age 7, and lung function at age 7. We defined "probable asthma" at age 7 as currently taking asthma medication or having two or more of the following criteria: any current respira- Children whose mothers reported they had respiratory symptoms at age 7 (n = 54) were offered a bronchodilator test, for which they inhaled albuterol and repeated spirometry 20 minutes later.
A positive test was defined as 12%+ improvement from their best FEV 1 or FVC before the bronchodilator.
A child was considered to have eczema at age 7 if the mother reported a doctor's diagnosis of "eczema or an allergic skin rash" in the last year, and a child was considered to have aeroallergies if the mother reported "runny or itchy eyes apart from colds," "sneezing or a runny nose apart from colds," or a doctor's diagnosis of "hay fever or allergic rhinitis" in the last year.
| Cytokine detection
A secondary outcome of this study was the percentage of Th1
and Th2 cytokine-producing cells, and their ratio. Flow cytometry was used to detect Th1 and Th2 cells in unfrozen pediatric whole blood collected at ages 2, 5, and 7. Methods have been previously described. 30 We divided the number of Th1 and Th2 cells by the total number of CD4+ cells to obtain the percentage of Th1 and Th2 (Th1% and Th2%) cells, respectively. Th1:Th2 cell ratio was defined as Th1% divided by Th2%. not transformed; FEV 1 /FVC, FEF 25%-75% , Th1%, Th2%, and Th1:Th2 cell ratio were assessed as continuous log 10 -transformed variables.
| Statistical analysis
Thus, for each twofold increase in biomarker concentration, regression coefficients represent mean or percent difference in outcomes.
To determine the longitudinal association of cytokine variables at ages 2, 5, and 7, we used generalized estimating equations with Gaussian specification and an exchangeable correlation structure, including interaction terms for child age.
In demographically adjusted models, we included maternal age at birth, parity, household income as a proportion of poverty at baseline, and family history of asthma as confounders, as determined a priori via directed acyclic graphs. We then generated fully adjusted models controlling for additional chemical expo-
sure. In addition to the HMW phthalates and BPA discussed in We conducted generalized additive models (GAMs) for all associations to test for linearity of relationships. We controlled for the same covariates as in fully adjusted models and allowed for three equivalent degrees of freedom. Relationships were considered linear if the P-value was above 0.05.
BMA analyses were conducted in R 32 (Vienna, Austria) with the BMS package. 33 Descriptive statistics and regressions were conducted in Stata 14 (College Station, TX).
| RE SULTS
Most mothers were aged 18-29 at enrollment (76%), lived below 100% of the federal poverty index (61%), and were multiparous (68%); most children had no family history of asthma (90%) ( Table 1 ).
All plasticizer biomarkers were detected in over 90% of urine samples ( Table 2) . Correlations ranged as high as 0.73 (MCNP and MCOP) (Figure 1 ).
We categorized 37 children (11%) with probable asthma, 87 children (25%) with aeroallergies, and 23 children (7%) with eczema (Table 3) . Th1:Th2 cell ratios and Th1% increased as children aged, while Th2% stayed stable with age ( Table 3 ).
The posterior inclusion probabilities for each outcome are shown in increased odds for aeroallergies in demographically adjusted models. MBzP also showed an association with aeroallergies in fully adjusted models, and MCNP concentrations showed associations with increased odds for probable asthma and aeroallergies in demographically adjusted models. There were no associations with eczema. Table 5 shows associations between urinary biomarker con- 
| D ISCUSS I ON
We found that prenatal urinary concentrations of MCOP were associated with increased odds for probable asthma and with lower lung function at age 7, after controlling for demographic factors and related chemical exposures, and were associated with increased odds for aeroallergies in demographically adjusted models. MCNP concentrations were associated with increased odds for probable asthma and aeroallergies and with lower lung function in demographically adjusted models. MBzP concentrations were associated with lower lung function, and MCPP and BPA concentrations were associated with increased odds for aeroallergies in demographically adjusted models.
Previous studies of chemical exposures and respiratory and allergic outcomes have examined one biomarker at a time, failing to account for multiple exposures. We used BMA variable selection to identify potentially confounding biomarkers to control for, and results from these fully adjusted models showed markedly fewer associations than models adjusted for demographic confounders only.
When estimates were higher in fully adjusted models compared to demographically adjusted models, such as with MCOP and probable asthma, we believe this indicates reduced confounding by the presence of other related chemical biomarkers. Results from demographically adjusted models resemble those from other studies to a greater extent than do our fully adjusted models, suggesting that other studies' findings may be partially due to confounding by co-exposure to other chemicals.
Our strongest findings were with MCOP, a phthalate metabolite on which there have been few studies. Our results agree with the Dampness in Buildings and Health study that observed an association between living with polyvinyl chloride flooring, which may be a source of exposure to the parent compounds of MCOP and MCPP, at ages 1-3, and increased risk of asthma and aeroallergies, but not eczema, at ages 6-8. 34 Our results also agree with the cross-sectional associations found between MCOP, MCNP, and MCPP and asthma in participants aged 18 and over in the 2005-2006 NHANES study. 35 However, a French birth cohort study found no association between prenatal urinary concentrations of these chemicals and asthma or FEV 1 at age 5.
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Our study found many null associations, which could indicate a true lack of association or low power to detect associations due to low sample size. Specifically, unlike several other studies, 12 we did not find associations of in utero exposures to DEHP, BBzP, or BPA and probable asthma or allergy risk. One of these studies reported associations with early childhood but not in utero BPA, 37 which suggests that early childhood exposure to BPA may be more impactful on childhood lung health and may explain our null results.
Our study found little evidence of associations of prenatal ma- found no association between prenatal maternal urinary concentrations of or BPA and cord blood Th2 cytokine concentrations in infants 38 , while another found an association between prenatal maternal blood concentrations of BPA and higher Th2 cytokines in cord blood 39 . However, T helper cell-related immunity changes drastically from birth to age 2 40 , and these previous studies may not be appropriate comparisons.
One limitation of our study is that although the focus of this paper was atopic illnesses, some of our probable asthma cases may be non-atopic and our inability to differentiate atopic versus nonatopic cases obscures any differentiation by etiology. Our population is from a largely low-income Mexican-American farm working community, and may not be comparable to other study populations.
Our sample size was also relatively small, which may have resulted in lower power to detect differences. Additionally, as in all studies, type I and type II errors may have occurred. Our employment of BMA as a variable selection tool is a strength, though it should be noted that BMA does not adequately account for collinearity among variables. Although few of our included biomarkers were highly correlated, many are used in similar products and this is not corrected for in BMA. Intraclass correlation coefficients (ICCs) for these chemicals are generally low in our population (high molecular weight phthalates range from 0.14 to 0.37 and the ICC for BPA is 0.16), indicating high variability between samples. However, unlike many previous studies, our exposure estimates are based on two measures of urinary chemical concentrations during pregnancy rather than one. Our urinary biomarker measurements at two prenatal time points are also a strength because gestational exposure to environmental chemicals may influence lung development and function more substantially than later exposures. 41 Our comprehensive evaluation of atopic diseases in childhood is also a strength. We measured cytokine levels at several ages, spanning important periods in juvenile immune system development, and we measured lung function. We used an integrated classification of probable asthma based on a number of asthma-related variables, including bronchodilator responsiveness. However, while our probable asthma and aeroallergy case definitions were based on both symptoms and medical management, we were unable to apply the same rigor to our eczema cases, which were based only on maternal report of a doctor diagnosis of eczema in their children.
We observed that prenatal maternal urinary concentrations of biomarkers of exposure to HMW phthalates, particularly MCOP, a metabolite of DiNP, are associated with increased odds of probable asthma and aeroallergies at age 7, and with lower lung function at age 7. The potential clinical relevance of the slightly lower lung function of the exposed children is difficult to assess at one time point, but reduced lung function in childhood has been associated with lower lung function and increased risk of respiratory illness in adulthood. We found limited evidence that prenatal urinary concentrations of BPA are associated with increased odds of aeroallergies at age 7, and did not confirm findings of other studies that showed associations between BPA and respiratory symptoms. 
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